7 studies found for:    MPACT
Show Display Options
Rank Status Study
1 Recruiting Benefits of MPACT in Locally Advanced Head and Neck Cancer Patients Undergoing Chemoradiotherapy
Condition: Head and Neck Neoplasms
Intervention: Other: MPACT
2 Recruiting A Multi-centre, Prospective Surveillance to Assess Mid-term Performance of the Mpact Cup
Conditions: Osteoarthritis;   Arthritis;   Avascular Necrosis;   Fracture of the Femoral Neck or Head;   Congenital Hip Dysplasia
Intervention: Device: Mpact Acetabular Shell
3 Completed Impact of Myfortic on Gastrointestinal (GI) Prophylaxis in Maintenance Renal Transplant Patients
Condition: Kidney Transplantation
Intervention: Drug: GI medication
4 Completed Cardiac Computed Tomography In the Management of Patients With indeterminAte or inConclusive Stress Tests
Condition: Coronary Disease
5 Recruiting NCI-MPACT: Molecular Profiling-Based Assignment of Cancer Therapy for Patients With Advanced Solid Tumors
Condition: Neoplasms
Interventions: Drug: Temozolomide;   Drug: Everolimus;   Drug: Carboplatin;   Drug: Trametinib DMSO;   Drug: ABT-888;   Drug: MK-1775
6 Completed A Study to Collect Survival Data on Patients Previously Enrolled in Abraxane Pancreatic Cancer Study CA046.
Condition: Pancreatic Cancer
Intervention: Drug: ABI-007
7 Recruiting A Study of Nab-paclitaxel and Gemcitabine, in Elderly Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma
Condition: Pancreatic Carcinoma Metastatic
Intervention: Drug: Nab-paclitaxel 125 mg/m2 + Gemcitabine 1000 weeks 1,2,3/4

Indicates status has not been verified in more than two years